Portland Countdown: A Series of Conversations on Parkinson’s Disease with Dave Iverson & Jon Palfreman

Special Guest: Jeffrey Kordower, PhD

Another once promising disease-modifying strategy involves using growth-factors to revive weakened dopamine neurons. But recent research suggests that at diagnosis the neural damage may be so advanced that there may not be many neurons left to rescue.

To listen to more episodes of this podcast, visit our website: www.worldpdcoalition.org/?page=PortlandCountdown

Special Guest: Andres Lozano, MD, PhD, FRCSC, FRSC, FCAHS

To listen to more episodes of this podcast, visit our website: www.worldpdcoalition.org/?page=PortlandCountdown

Special Guest: Daniel Weintraub, MD

To listen to more episodes of this podcast, visit our website: www.worldpdcoalition.org/?page=PortlandCountdown

Special Guests: Helen Bronte-Stewart, MD, MS and Terry Ellis, PT, PhD

Everyone tells patients to get plenty of exercise. Neurologists seem to be saying that the amount of exercise you get is as important as the pills you take. Why? What does the research tell us? And what exercise is best?

To listen to more episodes of this podcast, visit our website: www.worldpdcoalition.org/?page=PortlandCountdown

Special Guests: Patrik Brundin, MD, PhD and Kimberley Gannon, PhD

Basic researchers are hard at work trying to understand the pathology of Parkinson's and discover new drug targets. One likely bad actor is a protein called alpha-synuclein. What do we know about how it kills brain cells and what might be done to stop it?

To listen to more episodes of this podcast, visit our website: www.worldpdcoalition.org/?page=PortlandCountdown

In the first episode of the Portland Countdown, we chat with Dr. Andrew Lees about The history of what we know about Parkinson's disease beginning with James Parkinson's famous essay in 1817 on through the current state of Parkinson's disease research.

To listen to more episodes of this podcast, visit our website: http://www.worldpdcoalition.org/?page=PortlandCountdown